Insulet Corporation
PublicLegal Name: Insulet Corporation · Common Name: Insulet · DataKPIX ID: DKX-001
Sign in to unlock private workspace actions for this company
Sign InCompany Summary
Insulet Corporation is a medical device company specializing in tubeless insulin delivery systems. The company's flagship OmniPod platform enables people with diabetes to manage insulin delivery without traditional tubing, offering a subscription-based consumable model centered on pod replacements. Insulet operates in the automated insulin delivery (AID) market through OmniPod 5, its most advanced system integrating continuous glucose monitor (CGM) data for automated dosing adjustments.
The company operates two principal segments: OmniPod (direct-to-patient and pharmacy channel) and Drug Delivery (partnerships with pharmaceutical companies for wearable drug delivery systems). International markets represent a growing share of revenue, with Europe being a significant contributor.
Founded
2000
Acton, Massachusetts
FY2023 Revenue
~$1.97B
+26% YoY growth
Gross Margin
~67%
Subscription-like model
Employees
~5,000
Global workforce
Primary Product
OmniPod 5
AID System — FDA cleared
Revenue Model
Recurring
Pod subscription basis
Key Markets
US + Europe
International expansion
Exchange
NASDAQ: PODD
S&P 500 component
UBPR Value Stream Map
Operating context mapped to Universal Business Process Reference (UBPR) framework
Strategy & Governance
High RelevanceInnovation & Engineering
High RelevanceSupply & Procurement
High RelevanceOperations & Manufacturing
High RelevanceCommercial & Customer
High RelevanceService & Asset Management
Medium RelevanceFinance & Risk
High RelevancePeople & Organization
Medium RelevanceDigital & Data
High Relevance